DATED JANUARY 22, 2021 THE SERIES C INVESTORS and THE SERIES B INVESTORS and THE SERIES A INVESTORS and THE QUALIFYING ORDINARY SHAREHOLDERS and IMMUNOCORE HOLDINGS LIMITED SHAREHOLDERS’ AGREEMENT relating to Immunocore Holdings Limited ContentsShareholder Agreement • July 21st, 2022 • General Atlantic, L.P. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 21st, 2022 Company Industry Jurisdiction
DATED JANUARY 22, 2021 THE SERIES C INVESTORS and THE SERIES B INVESTORS and THE SERIES A INVESTORS and THE QUALIFYING ORDINARY SHAREHOLDERS and IMMUNOCORE HOLDINGS LIMITED SHAREHOLDERS’ AGREEMENT relating to Immunocore Holdings Limited ContentsShareholder Agreement • May 20th, 2021 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 20th, 2021 Company Industry Jurisdiction